Skip to content

Author

Peter Repiscak

We have 1 of 25 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Jul 2026

Therapeutic targeting of β-catenin in cancer.

Effective targeting of β-catenin has the potential to address extensive unmet patient needs in hard-to-treat cancer types such as colorectal cancer, hepatocellular carcinoma as well as other cancers driven by WNT/β-catenin pathway alterations.

Paola Martinelli, Peter Repiscak, N. Kraut · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.